1. Home
  2. PRTA vs MCFT Comparison

PRTA vs MCFT Comparison

Compare PRTA & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$8.76

Market Cap

429.2M

Sector

Health Care

ML Signal

N/A

MCFT

MasterCraft Boat Holdings Inc.

N/A

Current Price

$20.00

Market Cap

477.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PRTA
MCFT
Founded
2012
1968
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
429.2M
477.1M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
PRTA
MCFT
Price
$8.76
$20.00
Analyst Decision
Buy
Hold
Analyst Count
7
7
Target Price
$21.40
★ $25.00
AVG Volume (30 Days)
★ 508.2K
138.5K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.26
N/A
Revenue
$814,000.00
★ $348,903,000.00
Revenue This Year
$754.03
$77.29
Revenue Next Year
N/A
$2.86
P/E Ratio
$32.27
★ N/A
Revenue Growth
N/A
★ 22.77
52 Week Low
$7.73
$17.19
52 Week High
$11.80
$28.44

Technical Indicators

Market Signals
Indicator
PRTA
MCFT
Relative Strength Index (RSI) 54.41 51.33
Support Level $8.08 $19.01
Resistance Level $9.18 $20.58
Average True Range (ATR) 0.38 0.59
MACD 0.03 0.18
Stochastic Oscillator 58.18 87.34

Price Performance

Historical Comparison
PRTA
MCFT

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc is a designer, manufacturer, and marketer of recreational powerboats sold through five brands: MasterCraft, Crest, Balise, Chaparral, and Robalo. It manufactures and sells recreational inboard, outboard, and sterndrive boats that it believes delivers superior performance for water skiing, wakeboarding, wakesurfing, and fishing, as well as general recreational boating. In addition, it offers various accessories, including trailers and aftermarket parts. Its segments are the Performance and Wake segment, consisting of the MasterCraft brand, which produces boats at its Vonore, Tennessee facility; The Leisure segment, consisting of Crest and Balise brands, which produces pontoon boats at its Owosso, Michigan facility; and the Recreation and Sport Fishing segment.

Share on Social Networks: